| Phase 2, Multi-Center, Double-Blind, Randomized, 2-Arm, Parallel Study to Assess the Efficacy and Safety of Ryanodex (EGL-4104) as Adjuvant Treatment in Subjects with Exertional Heat Stroke (EHS) |
Ongoing |
Dantrolene |
2 |
EGL-4104-C-1801 |
King Faisal General Hospital (Makkah), Mina Al-Jisr Hospital, Mina Al-Wadi Hospital, Mina Al-Shari' Al-Jadid Hospital |
| A two part seamless, open label, multi-center study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy. |
Terminated |
Risdiplam |
2 |
BP39056 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| "AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting." |
Ongoing |
Aflibercept |
4 |
191 57 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh) |
| The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2018: Randomized Double-Blind Placebo-controlled trial |
Ongoing |
Cinnamon |
3 |
100-18 |
King Abdulaziz University Hospital (Jeddah) |
| Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study |
Ongoing |
Apixaban |
4 |
2018-08 |
Saud Al-Babtain Cardiac Center (Dammam)N/A |
| An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD |
Ongoing |
Remsima |
4 |
RMS-KSA-20 |
King Abdulaziz University Hospital (Jeddah) |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma |
Ongoing |
Ibrutinib |
3 |
A051301 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| OPEN LABEL, RANDOMIZED, SINGLE SITE CLINICAL TRIAL TO COMPARE THE SAFETY & EFFICACY OF HERBAL MELANIN EXTRACTED FROM NIGELLA SATIVA SEEDS VS STANDARD OF CARE TREATMENT IN TREATING GASTRITIS PATIENTS |
Rejected |
Melanole NIGELLA SATIVA |
2 |
RC15/152/R |
N/A |
| Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. |
Ongoing |
Enoxa / Enoxaparin |
BE |
21-2017 v.02 |
Saudi Ajal |
| "A 12-week, multicenter, randomized, double-blind, placebo-controlledstudy to assess the efficacy and safety of QAW039 when added tostandard-of-care asthma therapy in patients with uncontrolled asthma" |
Ongoing |
QAW039/Fevipiprant |
3 |
CQAW039A2316 |
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
